If you or someone close to you struggles with alcohol use, it may help to know that medication originally developed for diabetes and obesitysemaglutide or other glucagon-like peptide-1 (GLP-1) receptor agonistsmay one day become a treatment for alcohol use disorder (AUD)
The research highlights the potential of semaglutide, the active ingredient in these medications, to serve as a new treatment for alcohol-use disorder, a condition responsible for about 178,000 deaths annually in the United States
How PlexusDx Supports a More Personalized Approach PlexusDx offers compounded GLP-1 medications at transparent, uninsured-friendly pricing ($129/mo to $349/mo) alongside optional genetic predisposition testing
Before treatment, 90% of surveyed patients reported frequent or constant food-related thoughts
As a result of its antioxidant potency, it helps protect the cardiovascular system from free radical damage, while its hypolipidaemic effect plays a part in preventing the accumulation of fat in the arteries
A rapid sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-Dye Binding
